Navigation Links
Mafraq Hospital Becomes First in United Arab Emirates to Deploy Masimo rainbow SET Pulse CO-Oximetry for State-of-the-Art Noninvasive Patient Monitoring
Date:2/10/2011

k hemoglobin levels in real-time without having to perform repeated, painful blood draws and time-consuming lab analyses."

Masimo Founder and CEO, Joe Kiani, stated, "We are happy to be partnering with Mafraq Hospital as they lead the UAE in advancing the care and safety of patients.  Mafraq Hospital's adoption of Masimo rainbow SET now makes it possible for hospital clinicians to noninvasively monitor and continuously track key indicators of a patient's relative physiological status—including hemoglobin and other blood constituents as well as fluid volume and respiration rate—to immediately and painlessly identify abnormalities and detect potentially life-threatening conditions much earlier."

The CEO of Emitac Healthcare Solutions (EHS), Masimo's distributor in the UAE, Mr. Raghavan Srinivasan considers it a matter of pride to partner with Masimo in deploying this solution to Mafraq Hospital, stating that: "This is a progressive step by the hospital to adopt innovative means to providing quality healthcare in the country."  

About Mafraq HospitalMafraq Hospital was established in 1983 and is one of the largest tertiary referral treatment hospitals in the United Arab Emirates, with 451 licensed beds. Its specialist services include medicine, obstetrics, pediatrics, as well as surgical and critical care services.  Mafraq Hospital operates the largest burn unit in the country and is a Center of Excellence for ENT and Thoracic surgery. The hospital also operates two primary healthcare clinics at Bani Yas and Al Nahda. Mafraq Hospital is part of the SEHA Health System and is owned and operated by Abu Dhabi Health Services Company PJSC (SEHA) which is responsible for the curative activities of the public hospitals and clinics of the Emirate of Abu Dhabi.   It is managed by Bumrungrad International (BIL), one of the most noted hospital management companies in Asia.  Mafraq Hospital physicians are amongst the be
'/>"/>

SOURCE Masimo
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Ness County Hospital Selects ChartAccess® Comprehensive EHR from Prognosis Health Information Systems
2. IPC The Hospitalist Company, Inc. to Report Fourth Quarter 2010 Results
3. Missouri Baptist Medical Center - Only Non-Teaching Hospital in Region to Offer Colorectal Cancer Patients Robotic Surgery
4. CareCentrix to Present at Hospital Readmissions Conference
5. If Hospitals Want a Competitive Advantage - Use Brain Monitors in Surgeries Requiring Sedation says Renowned Anesthesiologist
6. eCareSoft Launches Comprehensive EHR for Small & Medium Hospitals
7. BD and Rady Childrens Hospital-San Diego Announce Innovative Pilot Project to Reduce Environmental Impact of Sharps Disposal
8. Reportlinker Adds Hospital MRI (Magnetic Resonance Imaging/Tomography) Census
9. Reportlinker Adds Hospital Mammography Census
10. Reportlinker Adds Hospital Radiography & Fluoroscopy Census
11. Reportlinker Adds Hospital Angiography Census
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... , Jan. 15, 2014  Echo Therapeutics, Inc. (Nasdaq: ... its Symphony® CGM System as a non-invasive, wireless continuous ... Doman , Executive Chairman and Interim CEO of Echo ... Tenth Annual Equity Conference. Mr. Doman ...
(Date:1/15/2014)... 2014 Reportlinker.com announces that a new ... catalogue: PharmaPoint: Atopic ... Analysis to 2022 http://www.reportlinker.com/p01957657/PharmaPoint-Atopic-Dermatitis---India-Drug-Forecast-and-Market-Analysis-to-2022.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pathology ... India Drug Forecast and Market Analysis to ...
(Date:1/15/2014)... , Jan. 15, 2014  Zafgen, Inc., a leading ... of severely obese patients, today announced initial results ... selective inhibitor of methionine aminopeptidase 2 (MetAP2), in ... of genetic obesity.  These results showed improvements in ...
Breaking Medicine Technology:Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 2PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 4PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 5Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4
... Walmart (NYSE: WMT ) and Eli Lilly and Company ... affordable insulin option for people with diabetes.   , ... Beginning in mid-September, Lilly,s Humulin ® brand of ... name Humulin ® ReliOn ®, including 10 mL vials of Humulin® ...
... NASHVILLE, Tenn. , June 21 Emdeon Inc. (NYSE: ... payment cycle management solutions, today announced the acquisition of Chapin Revenue ... is a leading technology-enabled provider of hospital-based revenue cycle services including ... , , ...
Cached Medicine Technology:Walmart, Lilly Team Up to Provide Human Insulin to People With Diabetes 2Walmart, Lilly Team Up to Provide Human Insulin to People With Diabetes 3Walmart, Lilly Team Up to Provide Human Insulin to People With Diabetes 4Walmart, Lilly Team Up to Provide Human Insulin to People With Diabetes 5Emdeon Acquires Chapin to Enhance Provider-Focused Payment Integrity 2Emdeon Acquires Chapin to Enhance Provider-Focused Payment Integrity 3Emdeon Acquires Chapin to Enhance Provider-Focused Payment Integrity 4
(Date:4/17/2014)... California, San Diego School of Medicine report that older ... recent major loss are more likely to be compassionate ... is published in this month,s issue of the ... behaviors are associated with better health and well-being as ... to improve the outcomes of individuals whose deficits in ...
(Date:4/17/2014)... NY In a review published in the April ... president of The Feinstein Institute for Medical Research, says ... medical community,s approach to treating sepsis, which ... Americans. , Sepsis occurs when molecules released into the ... throughout the body. Inflammation is necessary for maintaining good ...
(Date:4/17/2014)... A Northwestern University synthetic biology team has created ... create programmable therapeutics that could travel the body ... disease. , Engineering cell-based, biological devices that monitor ... in clinical synthetic biology. However, no existing technology ... a patient,s physiological state and respond in a ...
(Date:4/17/2014)... MAYWOOD, Il. (April 17, 2014) Doctors who ... disease called lymphangioleiomyomatosis (LAM) can face an agonizing ... progression of the disease and help relieve shortness ... lung transplants, and sirolimus can cause potentially fatal ... said pulmonologist Dr. Daniel Dilling, medical director of ...
(Date:4/17/2014)... The cause of neuronal death in Parkinson,s disease is ... may be mistaken for foreign invaders and killed by ... autoimmune diseases like type I diabetes, celiac disease, and ... published April 16, 2014, in Nature Communications . ... in Parkinson,s disease; but if true, it could lead ...
Breaking Medicine News(10 mins):Health News:The ilk of human kindness 2Health News:Feinstein Institute researcher publishes new perspective on sepsis 2Health News:Building 'smart' cell-based therapies 2Health News:Patients with rare lung disease face agonizing treatment dilemma 2Health News:Patients with rare lung disease face agonizing treatment dilemma 3Health News:Is Parkinson's an autoimmune disease? 2
... growth worsens ovarian cancer, but its production can be stifled ... nanoparticle, a research team led by scientists at The University ... Journal of the National Cancer Institute. , "The protein interleukin-8 ... senior author Anil Sood, M.D., professor in the M. D. ...
... Works to Help Hollywood ,Stay Sane in an Insane ... ... Roy, M.A., "The,Industry Therapist" ( http://www.theIndustryTherapist.com ) is asking the,question why the ... Spears, mental illness., "Heath Ledger,s death is being treated with kid ...
... Feb. 26 Hologic, Inc.,(Nasdaq: HOLX ) today ... at the Raymond James & Associates 29th Annual,Institutional Investors ... Grand Cypress Hotel in Orlando, FL., Interested parties ... of,Hologic,s investor presentation on Monday, March 3, 2008 at ...
... clots, study says, , , TUESDAY, Feb. 26 (HealthDay News) ... associated with cancer treatment-related anemia may do more harm ... , The drugs -- erythropoiesis-stimulating agents (ESAs) -- increase ... risk of blood clots known as venous thromboembolisms (VTE) ...
... Increased ... 3.85% and 2.96%, Respectively, MEXICO CITY, Feb. 26 ... one of the leading Mexican,distributors of pharmaceutical products, beauty aids, ... its consolidated financial and operating results for the fourth,quarter of ...
... 26 Schnitzer West announced today,that one of the ... Coast gym in The Shops at The Bravern in ... time to meet the needs of approximately 2,300,Microsoft employees ... of the,project beginning this fall., DavidBartonGym will offer ...
Cached Medicine News:Health News:Researchers identify and shut down protein that fuels ovarian cancer 2Health News:Researchers identify and shut down protein that fuels ovarian cancer 3Health News:Hologic to Present at the Raymond James & Associates 29th Annual Institutional Investors Conference 2Health News:Anemia Drugs for Cancer Patients Increase Death Risk 2Health News:Anemia Drugs for Cancer Patients Increase Death Risk 3Health News:Grupo Casa Saba Announces Fourth Quarter 2007 Results 2Health News:Grupo Casa Saba Announces Fourth Quarter 2007 Results 3Health News:Grupo Casa Saba Announces Fourth Quarter 2007 Results 4Health News:World-Famous DavidBartonGym Buffs up the Bravern 2Health News:World-Famous DavidBartonGym Buffs up the Bravern 3
... This unique system uses prolene as thread-guide ... The hollow Ritleng Probe is inserted into the ... fed through it. The probe is then withdrawn ... mm 0.64 mm diam silicone tubing into place. ...
To maintain the conjunctival cul-de-sacs after enucleation or evisceration without hindering lid closure....
... collarette conforms to natural anatomy of ... Pre-loaded on disposable inserter/dilator instrument for ... forceps. The Micro-Large plugs feature the ... natural shape of the eyelid. The ...
With side bite Instrument recommended to catch the polypropylene thread in the nose....
Medicine Products: